Literature DB >> 18000376

The dynamics of cancer chromosomes and genomes.

C J Ye1, G Liu, S W Bremer, H H Q Heng.   

Abstract

A key feature of cancer chromosomes and genomes is their high level of dynamics and the ability to constantly evolve. This unique characteristic forms the basis of genetic heterogeneity necessary for cancer formation, which presents major obstacles to current cancer diagnosis and treatment. It has been difficult to integrate such dynamics into traditional models of cancer progression. In this conceptual piece, we briefly discuss some of the recent exciting progress in the field of cancer genomics and genome research. In particular, a re-evaluation of the previously disregarded non-clonal chromosome aberrations (NCCAs) is reviewed, coupled with the progress of the detection of sub-chromosomal aberrations with array technologies. Clearly, the high level of genetic heterogeneity is directly caused by genome instability that is mediated by stochastic genomic changes, and genome variations defined by chromosome aberrations are the driving force of cancer progression. In addition to listing various types of non-recurrent chromosomal aberrations, we discuss the likely mechanism underlying cancer chromosome dynamics. Finally, we call for further examination of the features of dynamic genome diseases including cancer in the context of systems biology and the need to integrate this new knowledge into basic research and clinical applications. This genome centric concept will have a profound impact on the future of biological and medical research. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 18000376     DOI: 10.1159/000108306

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  16 in total

1.  Programmed loss of millions of base pairs from a vertebrate genome.

Authors:  Jeramiah J Smith; Francesca Antonacci; Evan E Eichler; Chris T Amemiya
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-26       Impact factor: 11.205

2.  Development and analysis of a germline BAC resource for the sea lamprey, a vertebrate that undergoes substantial chromatin diminution.

Authors:  Jeramiah J Smith; Andrew B Stuart; Tatjana Sauka-Spengler; Sandra W Clifton; Chris T Amemiya
Journal:  Chromosoma       Date:  2010-03-02       Impact factor: 4.316

Review 3.  Aneuploidy and tumorigenesis.

Authors:  Xiao Fang; Pumin Zhang
Journal:  Semin Cell Dev Biol       Date:  2011-03-15       Impact factor: 7.727

4.  Chromosomal heterogeneity and instability characterize pediatric medulloblastoma cell lines and affect neoplastic phenotype.

Authors:  Angel Mauricio Castro-Gamero; Kleiton Silva Borges; Regia Caroline Lira; Augusto Faria Andrade; Paola Fernanda Fedatto; Gustavo Alencastro Veiga Cruzeiro; Ricardo Bonfim Silva; Aparecida Maria Fontes; Elvis Terci Valera; Michael Bobola; Carlos Alberto Scrideli; Luiz Gonzaga Tone
Journal:  Cytotechnology       Date:  2013-01-17       Impact factor: 2.058

5.  Chromosome-wide gene dosage rebalance may benefit tumor progression.

Authors:  Honglei Zhang; Xing Yang; Xu Feng; Haibo Xu; Qin Yang; Li Zou; Mei Yan; Dequan Liu; Xiaosan Su; Baowei Jiao
Journal:  Mol Genet Genomics       Date:  2018-03-15       Impact factor: 3.291

6.  Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer.

Authors:  Christine J Ye; Joshua B Stevens; Guo Liu; Steven W Bremer; Aruna S Jaiswal; Karen J Ye; Ming-Fong Lin; Lesley Lawrenson; Wayne D Lancaster; Markku Kurkinen; Joshua D Liao; C Gary Gairola; Malathy P V Shekhar; Satya Narayan; Fred R Miller; Henry H Q Heng
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

7.  Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome.

Authors:  J Pal; R Bertheau; L Buon; A Qazi; R B Batchu; S Bandyopadhyay; R Ali-Fehmi; D G Beer; D W Weaver; R J Shmookler Reis; R K Goyal; Q Huang; N C Munshi; M A Shammas
Journal:  Oncogene       Date:  2011-03-21       Impact factor: 9.867

8.  Stress, genomic adaptation, and the evolutionary trade-off.

Authors:  Steven D Horne; Saroj K Chowdhury; Henry H Q Heng
Journal:  Front Genet       Date:  2014-04-23       Impact factor: 4.599

9.  Why it is crucial to analyze non clonal chromosome aberrations or NCCAs?

Authors:  Henry H Q Heng; Sarah M Regan; Guo Liu; Christine J Ye
Journal:  Mol Cytogenet       Date:  2016-02-13       Impact factor: 2.009

10.  Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer.

Authors:  Pierre P Massion; Yong Zou; Hasmet Uner; Porntip Kiatsimkul; Holly J Wolf; Anna E Baron; Tim Byers; Steinn Jonsson; Stephen Lam; Fred R Hirsch; York E Miller; Wilbur A Franklin; Marileila Varella-Garcia
Journal:  PLoS One       Date:  2009-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.